Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Taking Victoza with insulin (as well as other medications such as sulfonylureas that also lower blood sugar levels) increases your risk of hypoglycemia (low blood sugar levels) so monitor yourself for symptoms of low blood sugar which include sweating, shaking, dizziness, a fast heartbeat, and mood changes
Along with its greater weight loss and blood sugar control comes the potential for more intense side effects
doi: 10.1016/j.brainres.2007.01.107 143 LeibelRLChungWKChuaSC
Retatrutide is a triple agonist (GIP, GLP-1, and glucagon receptors) while Ozempic activates only GLP-1 receptors, resulting in significantly greater weight loss, 24.2% versus 14.9% at standard doses
Current Availability and Regulatory Status in the UK Retatrutide is not approved for clinical use in the UK as of April 2025 and can only be accessed through MHRA-registered clinical trials
The most effective GLP-1 weight loss programs combine medical support with healthy habits and personalized guidance
US$ 28.48
US$ 28.23
US$ 26.02
US$ 29.41
